Study S001683

SEMAFOLLOW - Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity: Observational, National Cohort, Real-world Study in France

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07423481
Acronym: SEMAFOLLOW
Study type: OBSERVATIONAL
Status: NOT_YET_RECRUITING
Enrollment: 3000
Start: 2026-10-01
Primary completion: 2027-07-01
Lead sponsor: Nantes University Hospital
Conditions: Obesity & Overweight
Interventions: OTHER:SEMAFOLLOW questionnaire
Results posted: FALSE
Individual participant data sharing: UNDECIDED
Secondary identifiers: OTHER:2026-A00299-42

Registered primary outcomes

Describe weight changes during the follow-up period according to patient characteristics. [Baseline]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.